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Abstract
Fat embolism syndrome (FES) is a clinical syndrome characterized by signs and symp-
toms resulting from fat emboli and typically occurs after trauma, orthopaedic surgeries 
and non-traumatic conditions like acute pancreatitis. Literature reports an incidence of 
FES of up to 19% in prospective studies. Fat embolism refers to the presence of fat glob-
ules in pulmonary microcirculation and is often asymptomatic. The clinical syndrome 
of FES is characterized by systemic manifestations resulting from fat emboli which may 
manifest with a triad of lung, brain, and skin involvement in about 24–72 hours of asymp-
tomatic period. The pathophysiology of fat embolism syndrome remains unclear. Two 
theories have been hypothesized: mechanical(disruptive) and biochemical(production of 
toxic metabolites). Universal agreement on the definition of FES is lacking. FES presents 
with nonspecific signs and symptoms;common to other critical illnesses and is often a 
diagnosis of exclusion. The clinical criteria proposed by Gurd and Wilson are popular. 
Biochemical tests and imaging may be of value in supporting the diagnosis. Treatment 
for FES is essentially supportive care in ICU. Principles of treatment include maintenance 
of adequate oxygenation, ventilation, hemodynamics, and organ perfusion. It may be 
prevented by early fixation of large bone fractures.
Keywords: fat embolism syndrome (FES), long bone fractures, clinical criteria, imaging 
studies, supportive care, early fixation
1. Introduction
The term “fat embolism” (FE) is often loosely used to describe both fat embolization (of insig-
nificant clinical relevance) and the clinical syndrome of fat embolism syndrome (FES) [1]. 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The term “fat embolism” may be defined as the presence of fat globules in the pulmonary 
microcirculation irrespective of its clinical relevance, while the clinical syndrome of FES is 
characterized by the clinical signs and symptoms (systemic manifestations) resulting from 
fat emboli [2] and must be differentiated from the pathophysiological phenomenon of fat 
embolization [3].
2. History
Fat embolism was described as early as 1862 by Zenker. Warthin [4] opined that fat embolism 
from traumatic lipemia was not rare and the most frequent cause of death following long 
bone fractures in the absence of infection.
More data on FES came forth in the early twenty‐first century from wounded soldiers involved 
in armed conflict across the world. A series of 1000 combats injured in the World War II 
reported the incidence of FES to be 0.8%. In Vietnam, cases of arterial hypoxemia among 
wounded soldiers were attributed to FES and also reported a few classic presentations of 
FES [3].
3. Pathophysiology
The pathophysiology of development of fat embolism syndrome is still unclear. However, 
two theories were hypothesized for its mechanism: mechanical and biochemical. Either the 
disrupted fat globules from bone marrow or adipose tissues enter into the bloodstreams 
(mechanical) or any sequel that leads to the production of toxic metabolites in the blood (bio-
chemical) can give rise to a conundrum of clinical features that characterize the fat embolism 
syndrome. It is also likely that either the mechanisms exist in tandem or one gives rise to the 
other in the production of FES.
3.1. Mechanical theory
In the twentieth century, it was suggested that following a trauma, fat particles from the bone 
marrow and adipose tissues enter into the disrupted venules and travel to the pulmonary 
circulation or enter into the systemic circuit via arteriovenous shunts. The echocardiographic 
finding of echogenic material passing into the right heart during an orthopedic procedure 
contributed to this mechanical theory [5].
3.2. Biochemical theory
However, the mechanical theory does not explain the development of FES after a delay of 
2–3 days postinjury. There are many biochemical mechanisms involved in the progression 
of fat embolism syndrome; the most widely accepted is the release of free fatty acids into 
the plasma following trauma, sepsis, and/or systemic inflammation. Acute phase reactants, 
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like C-reactive proteins, lead to lipid agglutination that tend to cause Acute respiratory dis-
tress syndrome (ARDS) in animal models, dysfunction of cardiac contractility and increase 
in plasma lipase concentration, which are the features of FES. These free fatty acids migrate 
to other organs, causing multiorgan failure [6]. This theory also helps in understanding the 
development of nontraumatic fat embolism syndrome.
4. Incidence
Fat Embolism is common in trauma patients, particularly those with pelvic or long bone frac-
tures [3]. Most literature reporting incidence of FES involves orthopedic or trauma patients 
with retrospective studies reporting an incidence of below 1%, while prospective studies have 
reported a much higher incidence of 11–19% [7]. Autopsy studies reported a much higher 
incidence of Fat embolism. One study demonstrated pulmonary fat emboli in 82% of trauma 
patients at autopsy [8]. Up to 67% of trauma patients without clinical features of fat embolism 
syndrome were shown to have circulating fat globules [3].
Fat emboli with a diameter of more than 20 µm have been shown to occur in up to 90% of 
patients with long bone fractures. Another study concluded that more than 90% of patients 
with long bone fractures had embolism with fat droplets more than 20 µm in diameter [9].
Gurd proposed that the clinical syndrome of fat embolism can be differentiated from a mere 
presence of fat emboli at autopsy in patients with no prior clinical features. Gurd suggested 
that a distinction can be made between the clinical syndrome of fat embolism and demonstra-
tion of fat embolism on autopsy with no prior clinical features of the syndrome [10].
Bulger et al. studied the incidence of FES at a level I trauma center over a 10‐year period, 
reporting an incidence of 0.9% among patients with long bone fractures [11]. More recent data 
from the National Hospital Discharge Survey in USA looking at 21,538,000 patients with long 
bones and pelvic fractures reported a diagnosis of FES in 0.12% of the patients [12].
5. Etiology and risk factor
The development of FES is frequently associated following an orthopedic trauma, with high-
est occurrence in closed and/or multiple long bone fractures, particularly of lower limb bones 
like femur. Aggressive nailing of the medullary canal poses increased risk of FES. Vigorous 
nailing of medullary cavity during intramedullary nailing and increase in gap between nail 
and cortical bone puts the patient at high risk of developing FES [6].
Furthermore, younger populations of 10–40 years and men more often than women are at 
high risk. Fat embolism has been reported in other nontraumatic conditions like pancreati-
tis, liposuction, bone marrow transplant, sickle cell disease, and liver disease. Nontraumatic 
causes of fat embolism syndrome include bone marrow transplant, pancreatitis, liposuction, 
alcoholic liver disease, and sickle cell crisis [13].
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6. Clinical features
The phenomenon of fat embolism (fat droplets in circulation) is often undiagnosed in clini-
cal practice. The clinical syndrome of FES tends to present with signs and symptoms similar 
to other critical illness and is mostly a diagnosis of exclusion. Fat embolism, which is a mere 
presence of fat emboli in circulation, may frequently go undiagnosed [10], while fat embolism 
syndrome presents with nonspecific clinical features common to other critical illnesses and is 
often a diagnosis of exclusion.
The fulminating form may present with sudden cardiovascular collapse and right ventricular 
failure subsequent to pulmonary and systemic fat embolization. More often, it is character-
ized by a more gradual onset of hypoxemia, neurological symptoms and a petechial rash 
about 12–36 hours after an injury [7].
Fat emboli could travel through the systemic vasculature resulting in a multiorgan disease 
involving lungs, brain, skin, retina, kidneys, liver, and heart.
The most common manifestations among patients with FES are of pulmonary system. 
Pumonary manifestations though of varying severity are the most common finding in patient 
with fat embolism syndrome. Bulger et al. reported hypoxemia in 96% of the cases, and 44% 
of the patients with FES required mechanical ventilation [11]. Patients may develop dyspnea 
and tachypnea and a more severe syndrome indistinguishable from Acute respiratory distress 
syndrome (ARDS) may develop.
Nonspecific neurological symptoms including lethargy, restlessness or a decrease in Glasgow 
Coma Scale (GCS) may suggest cerebral edema subsequent to FES [14]. Severe neurological 
deterioration with cerebral edema has been reported with FES [15].
Skin involvement characterized by a petechial rash manifests in up to 60% of patients and 
usually affects oral mucous membranes, neck and axilla skin folds and conjunctiva. Dermal 
manifestations with a petechial rash pathogonomic of FES usually involves the conjunctiva, 
oral mucous membranes and skin folds of the neck and axillae and occuring in up to 60% of 
patients with FES [7].
7. Diagnosis
7.1. Gurd’s and Wilson’s criteria
Universal agreement on a standard definition of FES is lacking. There is a lack of universally 
accepted definition of FES [3]. The major and minor criteria proposed by Gurd and Wilson 
(Table 1) in 1970 are still popular [10]. It required one major criterion plus four minor criteria’s 
in addition to fat macroglobulinemia for a diagnosis of FES.
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7.2. Schonfeld’s criteria
Other authors later adapted these criteria and proposed the combinations of major and minor 
features needed for a diagnosis. Schonfeld et al. proposed (Table 3) a quantitative measure to 
diagnose FES; a score of more than 5 is required to diagnose FES [3].
7.3. Lindeque’s criteria
Lindeque proposed criteria for diagnosis of fat embolism syndrome based on respiratory 
changes alone [16]. A positive diagnosis of FES was proposed if atleast one of the criteria are 
met (Table 2).
1. Major criteria
a. Petechial rash
b. Respiratory insufficiency
c. Cerebral involvement
2. Minor criteria
a. Tachycardia
b. Fever
c. Retinal changes
d. Jaundice
e. Renal signs
f. Thrombocytopenia
g. Anemia
h. High ESR
i. Fat macroglobinemia
Table 1. Gurd’s and Wilson’s criteria (with permission from Dr. Nissar Shaikh) [6].
Scores
Petechiae 5
X‐Ray chest diffuse infiltrates 4
Hypoxemia 3
Fever 1
Tachycardia 1
Tachypnea 1
Confusion 1
Table 2. Lindeque’s criteria (with permission from Dr. Nissar Shaikh) [6].
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8. Investigations
Diagnosis must be made on the basis of clinical findings but biochemical changes may be of 
value to support in diagnosis.
In the initial stages, a blood gas analysis is imperative, which will show hypoxia with paO
2
 of 
less than 60 mmHg and hypocapnia within the first 24–48 hours. Also, there will be an unex-
plained increase in the pulmonary shunt fraction and an alveolar to arterial oxygen tension 
difference. These are highly suggestive of a diagnosis of FES.
Nonspecific findings include anemia, thrombocytopenia, hypofibrinogenemia and high eryth-
rocytes sedimentation rate. Cytological examination of urine, blood, sputum, and pulmonary 
capillary blood may detect fat globules in patients with FES; however, these tests are rarely 
done in the immediate period as they lack sensitivity and their absence does not rule out fat 
embolism [6].
8.1. Imaging studies
8.1.1. Chest X‐ray
Various nonspecific findings have been reported on chest X‐ray though none of them is diag-
nostic. Numerous radiological findings have been described but none is diagnostic of fat 
embolism syndrome. The chest X-ray is often normal initially but in some patients bilateral 
fluffy shadows can be seen with worsening respiratory insufficiency (Figure 1).
Sustained pO
2
 < 8 kpa
Sustained pCO
2
 > 7.3 kpa
Sustained respiratory rate > 35 per min, in spite of sedation
Increase work of breathing, dyspnea, tachycardia, anxiety
Schonfeld’s criteria
Petechiae 5
Chest X‐ray changes (diffuse alveolar infiltrates) 4
Hypoxaemia (Pao2 < 9.3 kPa) 3
Fever (>38°C) 1
Tachycardia (>120 beats min−1) 1
Tachypnoea (>30 bpm) 1
Cumulative score >5 required for diagnosis
Table 3. Schonfeld’s criteria (with permission from Dr. Nissar Shaikh) [6].
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8.1.2. Ventilation – perfusion scan (V/Q)
V/Q scans may demonstrate a mottled pattern of subsegmental perfusion defects with a nor-
mal ventilatory pattern.
8.1.3. CT – computerized tomography chest and head
Spiral CT scan of the chest may show focal areas of ground glass opacification with interlobu-
lar septal thickening. Normal findings or diffuse petechial hemorrhages of white matter may 
be seen on CT scan of brain. CT Head may be normal or reveal diffuse white‐matter petechial 
hemorrhages consistent with microvascular injury. This will also rule out other causes for 
deterioration in consciousness level (Figure 2).
Figure 1. AP radiograph of the chest showing bilateral basal air space‐filling lesions (consolidation in a patient of FES) 
(with permission from Dr. Nissar Shaikh) [6].
Figure 2. CT image showing minimal hypodense changes in periventricular region, which are more evident in MRI 
DWI and T2WI as areas of high signals (with permission from Dr. Nissar Shaikh) [6]. (Produced with permission) 
Constellation of findings along with clinical data is characteristic for FES.
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8.1.4. MRI of brain
It may reveal high-intensity T2 signal which correlates with the degree of neurological impair-
ment found clinically.
9. Treatment
Treatment is largely supportive care in a unit equipped with intensive care capabilities. 
Maintaining adequate oxygenation, ventilation, and organ perfusion are the essential goals 
of treatment. Principles of treatment include maintenance of adequate oxygenation and 
ventilation, hemodynamics, and perfusion. Correction of hypoxemia to maintain normal 
oxygen tension may require simple measures like oxygen supplementation or mechanical 
ventilation and Positive end expiratory pressure (PEEP) depending on the clinical context. 
Shock in patients with FES can worsen the lung injury and hence restoration of  intravascular 
volume with balanced salt solutions or albumin is often required. Albumin administration 
not only expands the intravascular volume but may also mitigate the extent of lung injury 
as a result of its binding with fatty acids. Vasopressors to maintain the hemodynamics may 
be required. It has been proposed that  heparin by enhancing lipase activity may augment 
the clearance of lipids from blood circulation. Treatment modalities including corticoste-
roids and anticoagulation have unfortunately not been shown to improve the morbidity 
or mortality. Other medications including alcohol and dextran have also been shown to be 
ineffective [2, 6].
10. Prognosis
Fat embolism occur in around 90% of all trauma patient, but FES accounts for less than 5% 
of patients having long bone fracture [17, 18]. The unstable form of FES presents as acute 
respiratory failure, cor pulmonale, and/or embolic event, leading to death within a few hours 
of injury. This is seen more often among high‐risk patients and those with a background of 
multiple comorbidities.
It is hard to predict the extent of FES as it is often subclinical and the outcome of patients are 
generally favorable [6]. Mortality rate is less than 10% at present as there have been significant 
improvements in supportive care. Neurological deficits and pulmonary manifestations usu-
ally resolve completely over time [18].
11. Prevention
Studies have shown early fixation of fractures involving long bones is important in decreas-
ing the incidence of fat embolism syndrome and may prevent it [6, 19, 20]. Preventing sig-
nificant increase in intraosseous pressure in orthopedic surgeries may reduce embolization 
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of fat droplets and thereby reduce the incidence of FES. It has been suggested that plate fixa-
tion and external fixation results in less emboli and less severity of lung injury than surgical 
fixation with intramedullary nailing [6]. Prophylactic use of corticosteroids may have a ben-
eficial effect in preventing fat embolism syndrome [21]. Wong et al. suggested monitoring 
with continuous pulse oximetry in patients with long bone fractures for early identification 
of desaturation [22]. This would allow early initiation of appropriate oxygen supplemen-
tation and other measures, possibly reducing the systemic complications of fat embolism 
syndrome [6].
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